Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.
Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasing incidences of cance.
Market Analysis and Insights: Global Circulating Tumor Cells (CTC) Market
The global Circulating Tumor Cells (CTC) market size is projected to reach US$ 1316.1 million by 2026, from US$ 1078.5 million in 2020, at a CAGR of 20.4%% during 2021-2026.
Global Circulating Tumor Cells (CTC) Scope and Market Size
Circulating Tumor Cells (CTC) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Circulating Tumor Cells (CTC) Breakdown Data by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Circulating Tumor Cells (CTC) Breakdown Data by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasing incidences of cance.
Market Analysis and Insights: Global Circulating Tumor Cells (CTC) Market
The global Circulating Tumor Cells (CTC) market size is projected to reach US$ 1316.1 million by 2026, from US$ 1078.5 million in 2020, at a CAGR of 20.4%% during 2021-2026.
Global Circulating Tumor Cells (CTC) Scope and Market Size
Circulating Tumor Cells (CTC) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Circulating Tumor Cells (CTC) Breakdown Data by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Circulating Tumor Cells (CTC) Breakdown Data by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
1.4 Market by Type
1.4.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex-Vivo Positive Selection
1.4.3 In-Vivo Positive Selection
1.4.4 Negative Selection
1.4.5 Microchips & Single Spiral Micro Channel
1.5 Market by Application
1.5.1 Global Circulating Tumor Cells (CTC) Market Share by Application: 2020 VS 2026
1.5.2 Tumorigenesis Research
1.5.3 Emt Biomarkers Development
1.5.4 Cancer Stem Cell Research
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2015-2026)
2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Regions
2.2.1 Circulating Tumor Cells (CTC) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cells (CTC) Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Circulating Tumor Cells (CTC) Market Growth Strategy
2.3.6 Primary Interviews with Key Circulating Tumor Cells (CTC) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Market Size
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2015-2020)
3.1.3 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.2.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2019
3.3 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cells (CTC) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2015-2020)
6.2 Circulating Tumor Cells (CTC) Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2015-2020)
7.2 Circulating Tumor Cells (CTC) Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
8 China
8.1 China Circulating Tumor Cells (CTC) Market Size (2015-2020)
8.2 Circulating Tumor Cells (CTC) Key Players in China (2019-2020)
8.3 China Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Circulating Tumor Cells (CTC) Market Size (2015-2020)
9.2 Circulating Tumor Cells (CTC) Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cells (CTC) Market Size (2015-2020)
10.2 Circulating Tumor Cells (CTC) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
11 India
11.1 India Circulating Tumor Cells (CTC) Market Size (2015-2020)
11.2 Circulating Tumor Cells (CTC) Key Players in India (2019-2020)
11.3 India Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Circulating Tumor Cells (CTC) Market Size (2015-2020)
12.2 Circulating Tumor Cells (CTC) Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
12.4 Central & South America Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AdnaGen
13.1.1 AdnaGen Company Details
13.1.2 AdnaGen Business Overview
13.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
13.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2015-2020))
13.1.5 AdnaGen Recent Development
13.2 Apocell
13.2.1 Apocell Company Details
13.2.2 Apocell Business Overview
13.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
13.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.2.5 Apocell Recent Development
13.3 Biocep
13.3.1 Biocep Company Details
13.3.2 Biocep Business Overview
13.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
13.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.3.5 Biocep Recent Development
13.4 Canopus Bioscience
13.4.1 Canopus Bioscience Company Details
13.4.2 Canopus Bioscience Business Overview
13.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
13.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.4.5 Canopus Bioscience Recent Development
13.5 Creatv Microtech
13.5.1 Creatv Microtech Company Details
13.5.2 Creatv Microtech Business Overview
13.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
13.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.5.5 Creatv Microtech Recent Development
13.6 Ikonisys
13.6.1 Ikonisys Company Details
13.6.2 Ikonisys Business Overview
13.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
13.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.6.5 Ikonisys Recent Development
13.7 IV Diagnostics
13.7.1 IV Diagnostics Company Details
13.7.2 IV Diagnostics Business Overview
13.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
13.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.7.5 IV Diagnostics Recent Development
13.8 Miltenyi Biotech
13.8.1 Miltenyi Biotech Company Details
13.8.2 Miltenyi Biotech Business Overview
13.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
13.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.8.5 Miltenyi Biotech Recent Development
13.9 Nanostring Technologies
13.9.1 Nanostring Technologies Company Details
13.9.2 Nanostring Technologies Business Overview
13.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
13.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.9.5 Nanostring Technologies Recent Development
13.10 Rarecells Diagnostics
13.10.1 Rarecells Diagnostics Company Details
13.10.2 Rarecells Diagnostics Business Overview
13.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
13.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.10.5 Rarecells Diagnostics Recent Development
13.11 Vitatex
10.11.1 Vitatex Company Details
10.11.2 Vitatex Business Overview
10.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
10.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
10.11.5 Vitatex Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
1.4 Market by Type
1.4.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex-Vivo Positive Selection
1.4.3 In-Vivo Positive Selection
1.4.4 Negative Selection
1.4.5 Microchips & Single Spiral Micro Channel
1.5 Market by Application
1.5.1 Global Circulating Tumor Cells (CTC) Market Share by Application: 2020 VS 2026
1.5.2 Tumorigenesis Research
1.5.3 Emt Biomarkers Development
1.5.4 Cancer Stem Cell Research
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2015-2026)
2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Regions
2.2.1 Circulating Tumor Cells (CTC) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cells (CTC) Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Circulating Tumor Cells (CTC) Market Growth Strategy
2.3.6 Primary Interviews with Key Circulating Tumor Cells (CTC) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Market Size
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2015-2020)
3.1.3 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.2.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2019
3.3 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cells (CTC) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2015-2020)
6.2 Circulating Tumor Cells (CTC) Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2015-2020)
7.2 Circulating Tumor Cells (CTC) Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
8 China
8.1 China Circulating Tumor Cells (CTC) Market Size (2015-2020)
8.2 Circulating Tumor Cells (CTC) Key Players in China (2019-2020)
8.3 China Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Circulating Tumor Cells (CTC) Market Size (2015-2020)
9.2 Circulating Tumor Cells (CTC) Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cells (CTC) Market Size (2015-2020)
10.2 Circulating Tumor Cells (CTC) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
11 India
11.1 India Circulating Tumor Cells (CTC) Market Size (2015-2020)
11.2 Circulating Tumor Cells (CTC) Key Players in India (2019-2020)
11.3 India Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Circulating Tumor Cells (CTC) Market Size (2015-2020)
12.2 Circulating Tumor Cells (CTC) Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Tumor Cells (CTC) Market Size by Type (2015-2020)
12.4 Central & South America Circulating Tumor Cells (CTC) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AdnaGen
13.1.1 AdnaGen Company Details
13.1.2 AdnaGen Business Overview
13.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
13.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2015-2020))
13.1.5 AdnaGen Recent Development
13.2 Apocell
13.2.1 Apocell Company Details
13.2.2 Apocell Business Overview
13.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
13.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.2.5 Apocell Recent Development
13.3 Biocep
13.3.1 Biocep Company Details
13.3.2 Biocep Business Overview
13.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
13.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.3.5 Biocep Recent Development
13.4 Canopus Bioscience
13.4.1 Canopus Bioscience Company Details
13.4.2 Canopus Bioscience Business Overview
13.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
13.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.4.5 Canopus Bioscience Recent Development
13.5 Creatv Microtech
13.5.1 Creatv Microtech Company Details
13.5.2 Creatv Microtech Business Overview
13.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
13.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.5.5 Creatv Microtech Recent Development
13.6 Ikonisys
13.6.1 Ikonisys Company Details
13.6.2 Ikonisys Business Overview
13.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
13.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.6.5 Ikonisys Recent Development
13.7 IV Diagnostics
13.7.1 IV Diagnostics Company Details
13.7.2 IV Diagnostics Business Overview
13.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
13.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.7.5 IV Diagnostics Recent Development
13.8 Miltenyi Biotech
13.8.1 Miltenyi Biotech Company Details
13.8.2 Miltenyi Biotech Business Overview
13.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
13.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.8.5 Miltenyi Biotech Recent Development
13.9 Nanostring Technologies
13.9.1 Nanostring Technologies Company Details
13.9.2 Nanostring Technologies Business Overview
13.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
13.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.9.5 Nanostring Technologies Recent Development
13.10 Rarecells Diagnostics
13.10.1 Rarecells Diagnostics Company Details
13.10.2 Rarecells Diagnostics Business Overview
13.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
13.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
13.10.5 Rarecells Diagnostics Recent Development
13.11 Vitatex
10.11.1 Vitatex Company Details
10.11.2 Vitatex Business Overview
10.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
10.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2015-2020)
10.11.5 Vitatex Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
